Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aethlon Medical (AEMD) Equity Average (2016 - 2025)

Aethlon Medical filings provide 15 years of Equity Average readings, the most recent being $4.7 million for Q1 2025.

  • On a quarterly basis, Equity Average fell 29.3% to $4.7 million in Q1 2025 year-over-year; TTM through Mar 2025 was $4.7 million, a 29.3% decrease, with the full-year FY2025 number at $5.4 million, down 47.72% from a year prior.
  • Equity Average hit $4.7 million in Q1 2025 for Aethlon Medical, down from $5.2 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $23.8 million in Q3 2021 to a low of $4.7 million in Q1 2025.
  • Median Equity Average over the past 5 years was $14.1 million (2023), compared with a mean of $13.3 million.
  • Biggest five-year swings in Equity Average: soared 81.16% in 2022 and later crashed 58.64% in 2024.
  • Aethlon Medical's Equity Average stood at $21.7 million in 2021, then dropped by 14.52% to $18.6 million in 2022, then crashed by 51.73% to $9.0 million in 2023, then crashed by 42.26% to $5.2 million in 2024, then fell by 8.65% to $4.7 million in 2025.
  • The last three reported values for Equity Average were $4.7 million (Q1 2025), $5.2 million (Q4 2024), and $7.4 million (Q3 2024) per Business Quant data.